Sections
Log in
Top News
U.S. News World News Featured Voices
Odd News
Entertainment
Movies Music TV
Sports
Soccer NFL NBA MLB
Photos
News Entertainment Sports Features
More...
Defense Featured Science Health Video Archive Almanac
About Feedback Privacy Policy
About Feedback Privacy Policy
Search
Trending
Vaping
Cowboy pigeons
Impeachment
High-tech hospital
PetSmart horse
$120,000 banana
Alcohol
New Zealand volcano
Missing plane
Hospital shooting
Health News
Nov. 18, 2019 / 4:10 PM

Statins won't harm aging brains, and might even help

By
Steven Reinberg, HealthDay News
Over six years, researchers found no significant difference between memory and mental ability among those who did and didn't take statins. Photo by iminwon/Shutterstock

Concerns that cholesterol-lowering statin drugs can impair brain health appear to be unfounded, according to new research.

"Statins won't make you stupid or cause memory loss," said lead researcher Dr. Katherine Samaras, a professor of medicine at St. Vincent's Clinical School of Medicine in Darlinghurst, Australia.

And for some people at risk of dementia, statins like Lipitor (atorvastatin) and Crestor (rosuvastatin) may improve memory and mental functioning, her team found.

Many millions of people take statins because of heart disease or high cholesterol. But reports that the drugs could cause memory loss led the U.S. Food and Drug Administration in 2012 to require a black box warning on all statin medications, she said.

RELATED Cholesterol-lowering statins may not help many who take them

However, "we could find no overall impact on memory or any other aspect of cognitive function over six years in a large population of older people, who had extensive testing every two years," Samaras said.

The observational nature of this study means the research can't be considered conclusive, only that a strong link exists, the researchers noted.

"Any person who takes statins and is concerned about their memory and cognition should discuss this with their doctor. However, overall, we should be greatly reassured by the study findings," Samaras said.

RELATED People with familial high cholesterol at high cardiovascular risk, even with meds

For the study, she and her colleagues collected data on more than 1,000 people aged 70 to 90 who took part in the Sydney Memory and Aging Study. About 600 took statins and had done so for an average of nine years.

All of the participants had their memory and cognitive skills -- such as processing speed and language -- tested at the start of the study. No difference was seen between statin users and nonusers, according to the report.

Some people also had MRI scans to assess their brain volume. The MRIs showed no significant difference in brain volume among statin users and nonusers over two years.

RELATED Statin meds may lower risk of death for people with peripheral artery disease

And over six years, the researchers found no significant difference between memory and mental ability among those who did and didn't take the drugs.

Among 99 people who started taking statins during the study, however, Samaras and colleagues found statins were linked to a slower rate of memory loss.

As expected, statins did protect people with heart disease from heart attacks. Within this group, the drug also resulted in a slower rate of a decline in memory, compared with people who didn't take statins.

RELATED Statin prescriptions following heart attacks differ by region of U.S.

Moreover, in people with heart disease, diabetes or other risk factors for dementia, statin use slowed down mental decline in comparison with nonusers who had the same conditions.

Looking at people who had the APOE-4 gene mutation, which puts them at high risk for Alzheimer's disease, the researchers found statins appeared to significantly slow the rate of mental decline.

However, among participants without heart disease who took statins, the rate of memory decline was similar to those who didn't take the drug, the findings showed.

The report was published online Nov. 18 in the Journal of the American College of Cardiology.

Dr. Costantino Iadecola, a professor of neurology and neuroscience at Weill Cornell Medicine in New York City, co-authored an editorial accompanying the study. He said, "Statins have many effects on the brain."

The brain is 80 percent fat and has the most cholesterol of any organ in the body, and is very sensitive to any changes in fat, said Iadecola.

"So it's not surprising that modulating cholesterol affects the brain," he said.

Reducing cholesterol in the brain may reduce two changes linked to Alzheimer's, namely beta-amyloid plaques and tau tangles, he noted.

But whether statins have a positive effect on preserving cognitive function requires more study, Iadecola said.

In the meantime, he doesn't advise taking statins for the sole purpose of maintaining your mental abilities, since these drugs can have side effects.

More information

For more on statins, head to the U.S. National Library of Medicine.

Copyright 2019 HealthDay. All rights reserved.

  • Topics
  • Alzheimer's Disease
  • Food and Drug Administration
  • Weill Cornell

Latest Headlines

Study: Weight loss may reduce type 2 diabetes risk by 37 percent
Health News // 34 minutes ago
Study: Weight loss may reduce type 2 diabetes risk by 37 percent
Dec. 10 (UPI) -- A study found that a 1 kg/m squared reduction in BMI in non-overweight individuals reduced reduced their risk for developing type II diabetes by as much as 37 percent.

'Smart' contacts to one day monitor eye health
Health News // 2 hours ago
'Smart' contacts to one day monitor eye health
Dec. 10 -- Eye doctors may someday use "smart" contact lenses to track patients' eye health, early research suggests.

Study links fertility treatment with slight increase in childhood cancer
Health News // 4 hours ago
Study links fertility treatment with slight increase in childhood cancer
Dec. 10 (UPI) -- A study found that children born following frozen embryo transfer were nearly three times more likely to be diagnosed with some form of cancer than those born to women who didn't use fertility treatment.

Superbugs may be breeding in makeup, accessories after use
Health News // 4 hours ago
Superbugs may be breeding in makeup, accessories after use
Dec. 10 -- Makeup is a daily staple for most women, but new research finds that 9 of 10 beauty products may harbor superbugs after they're opened.

High dose of aspirin effective against migraines for some
Health News // 5 hours ago
High dose of aspirin effective against migraines for some
Dec. 10 -- A cheap, century-old drug in most Americans' medicine cabinets -- aspirin -- may come to the rescue for people with migraines, a new study finds, with a high dose treating headaches and lower one preventing them.

Terpenes in marijuana vaping products may produce toxic chemicals
Health News // 12 hours ago
Terpenes in marijuana vaping products may produce toxic chemicals
Dec. 10 -- Natural compounds removed from marijuana during distillation for e-liquids and concentrates, and added back in for taste and smell, may produce toxic chemicals in the vapor that users inhale, a new lab study reports.

'Superbug' risk poses greater threat to health, crops than thought
Health News // 13 hours ago
'Superbug' risk poses greater threat to health, crops than thought
Dec. 10 -- The risk of new superbugs that pose a threat to human health and food crops is much higher than previously thought, new genetic research shows.

Study: Regular pot use during pregnancy bad for baby
Health News // 17 hours ago
Study: Regular pot use during pregnancy bad for baby
Dec. 9 -- Smoking pot regularly during pregnancy won't do your baby any favors, researchers warn, based on sonograms from daily users that link consumption to delayed fetal growth and other health issues before and after birth.

Diabetes patients turning to black market as costs skyrocket
Health News // 21 hours ago
Diabetes patients turning to black market as costs skyrocket
Dec. 9 -- Skyrocketing prices and insurance limits are driving many people with diabetes to seek medications and supplies from an underground supply chain, a new study found.

Study: Light drinking may increase cancer risk by nearly 20 percent
Health News // 21 hours ago
Study: Light drinking may increase cancer risk by nearly 20 percent
Dec. 9 (UPI) -- A new study suggests that even light alcohol consumption may increase overall cancer risk when compared to people who do not drink at all, increasing risk for various cancers by about 18 percent.

Trending Stories

Terpenes in marijuana vaping products may produce toxic chemicals
Terpenes in marijuana vaping products may produce toxic chemicals
Study: Light drinking may increase cancer risk by nearly 20 percent
Study: Light drinking may increase cancer risk by nearly 20 percent
Diabetes patients turning to black market as costs skyrocket
Diabetes patients turning to black market as costs skyrocket
Clinical trial to test stem cells against type 1 diabetes
Clinical trial to test stem cells against type 1 diabetes
Obesity linked to changes in brain structure, impulsivity
Obesity linked to changes in brain structure, impulsivity

Photo Gallery

 
Dwayne Johnson, Jack Black attend 'Jumanji: The Next Level' premiere in LA
Dwayne Johnson, Jack Black attend 'Jumanji: The Next Level' premiere in LA

Latest News

Escaped dog traveled 65 miles before being caught
Pew: Veteran-led households have higher incomes than non-vet homes
Study: Weight loss may reduce type 2 diabetes risk by 37 percent
'Irishman' watched by 26M members in first week, Netflix says
Maryland man attributes lottery luck to Taylor Swift
 
Back to Article
/
Back to top
About UPI Contact Feedback Advertisements Submit News Tips
Copyright © 2019 United Press International, Inc. All Rights Reserved.
Terms of UsePrivacy Policy